Global and United States Infectious Disease Clinical Trials Market Report & Forecast 2022-2028
Table of Contents
1 Study Coverage
- 1.1 Infectious Disease Clinical Trials Revenue in Infectious Disease Clinical Trials Business (2017-2022) & (US$ Million) Introduction
- 1.2 Global Infectious Disease Clinical Trials Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Infectious Disease Clinical Trials Market Size for the Year 2017-2028
- 1.2.2 Global Infectious Disease Clinical Trials Market Size for the Year 2017-2028
- 1.3 Infectious Disease Clinical Trials Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.3.1 The Market Share of United States Infectious Disease Clinical Trials in Global, 2017 VS 2022 VS 2028
- 1.3.2 The Growth Rate of Infectious Disease Clinical Trials Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4 Infectious Disease Clinical Trials Market Dynamics
- 1.4.1 Infectious Disease Clinical Trials Industry Trends
- 1.4.2 Infectious Disease Clinical Trials Market Drivers
- 1.4.3 Infectious Disease Clinical Trials Market Challenges
- 1.4.4 Infectious Disease Clinical Trials Market Restraints
- 1.5 Study Objectives
- 1.6 Years Considered
2 Infectious Disease Clinical Trials by Type
- 2.1 Infectious Disease Clinical Trials Market Segment by Type
- 2.1.1 Phase I
- 2.1.2 Phase II
- 2.1.3 Phase III
- 2.1.4 Phase IV
- 2.2 Global Infectious Disease Clinical Trials Market Size by Type (2017, 2022 & 2028)
- 2.3 Global Infectious Disease Clinical Trials Market Size by Type (2017-2028)
- 2.4 United States Infectious Disease Clinical Trials Market Size by Type (2017, 2022 & 2028)
- 2.5 United States Infectious Disease Clinical Trials Market Size by Type (2017-2028)
3 Infectious Disease Clinical Trials by Application
- 3.1 Infectious Disease Clinical Trials Market Segment by Application
- 3.1.1 Vaccines
- 3.1.2 Cell & Gene Therapy
- 3.1.3 Others
- 3.2 Global Infectious Disease Clinical Trials Market Size by Application (2017, 2022 & 2028)
- 3.3 Global Infectious Disease Clinical Trials Market Size by Application (2017-2028)
- 3.4 United States Infectious Disease Clinical Trials Market Size by Application (2017, 2022 & 2028)
- 3.5 United States Infectious Disease Clinical Trials Market Size by Application (2017-2028)
4 Global Infectious Disease Clinical Trials Competitor Landscape by Company
- 4.1 Global Infectious Disease Clinical Trials Market Size by Company
- 4.1.1 Top Global Infectious Disease Clinical Trials Companies Ranked by Revenue (2021)
- 4.1.2 Global Infectious Disease Clinical Trials Revenue by Player (2017-2022)
- 4.2 Global Infectious Disease Clinical Trials Concentration Ratio (CR)
- 4.2.1 Infectious Disease Clinical Trials Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Companies of Infectious Disease Clinical Trials in 2021
- 4.2.3 Global Infectious Disease Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Infectious Disease Clinical Trials Headquarters, Revenue in Infectious Disease Clinical Trials Business (2017-2022) & (US$ Million) Type
- 4.3.1 Global Infectious Disease Clinical Trials Headquarters and Area Served
- 4.3.2 Global Infectious Disease Clinical Trials Companies Revenue in Infectious Disease Clinical Trials Business (2017-2022) & (US$ Million) Type
- 4.3.3 Date of International Companies Enter into Infectious Disease Clinical Trials Market
- 4.4 Companies Mergers & Acquisitions, Expansion Plans
- 4.5 United States Infectious Disease Clinical Trials Market Size by Company
- 4.5.1 Top Infectious Disease Clinical Trials Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States Infectious Disease Clinical Trials Revenue by Players (2020, 2021 & 2022)
5 Global Infectious Disease Clinical Trials Market Size by Region
- 5.1 Global Infectious Disease Clinical Trials Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Infectious Disease Clinical Trials Market Size by Region (2017-2028)
- 5.2.1 Global Infectious Disease Clinical Trials Market Size by Region: 2017-2022
- 5.2.2 Global Infectious Disease Clinical Trials Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Infectious Disease Clinical Trials Market Size YoY Growth 2017-2028
- 6.1.2 North America Infectious Disease Clinical Trials Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Infectious Disease Clinical Trials Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Infectious Disease Clinical Trials Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe Infectious Disease Clinical Trials Market Size YoY Growth 2017-2028
- 6.3.2 Europe Infectious Disease Clinical Trials Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Infectious Disease Clinical Trials Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Infectious Disease Clinical Trials Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.4.6 Colombia
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Infectious Disease Clinical Trials Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Infectious Disease Clinical Trials Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 IQVIA
- 7.1.1 IQVIA Company Details
- 7.1.2 IQVIA Business Overview
- 7.1.3 IQVIA Infectious Disease Clinical Trials Introduction
- 7.1.4 IQVIA Revenue in Infectious Disease Clinical Trials Business (2017-2022)
- 7.1.5 IQVIA Recent Development
- 7.2 LabCorp
- 7.2.1 LabCorp Company Details
- 7.2.2 LabCorp Business Overview
- 7.2.3 LabCorp Infectious Disease Clinical Trials Introduction
- 7.2.4 LabCorp Revenue in Infectious Disease Clinical Trials Business (2017-2022)
- 7.2.5 LabCorp Recent Development
- 7.3 Charles River
- 7.3.1 Charles River Company Details
- 7.3.2 Charles River Business Overview
- 7.3.3 Charles River Infectious Disease Clinical Trials Introduction
- 7.3.4 Charles River Revenue in Infectious Disease Clinical Trials Business (2017-2022)
- 7.3.5 Charles River Recent Development
- 7.4 WuXi AppTec
- 7.4.1 WuXi AppTec Company Details
- 7.4.2 WuXi AppTec Business Overview
- 7.4.3 WuXi AppTec Infectious Disease Clinical Trials Introduction
- 7.4.4 WuXi AppTec Revenue in Infectious Disease Clinical Trials Business (2017-2022)
- 7.4.5 WuXi AppTec Recent Development
- 7.5 Syneos Health
- 7.5.1 Syneos Health Company Details
- 7.5.2 Syneos Health Business Overview
- 7.5.3 Syneos Health Infectious Disease Clinical Trials Introduction
- 7.5.4 Syneos Health Revenue in Infectious Disease Clinical Trials Business (2017-2022)
- 7.5.5 Syneos Health Recent Development
- 7.6 PPD
- 7.6.1 PPD Company Details
- 7.6.2 PPD Business Overview
- 7.6.3 PPD Infectious Disease Clinical Trials Introduction
- 7.6.4 PPD Revenue in Infectious Disease Clinical Trials Business (2017-2022)
- 7.6.5 PPD Recent Development
- 7.7 ICON Plc
- 7.7.1 ICON Plc Company Details
- 7.7.2 ICON Plc Business Overview
- 7.7.3 ICON Plc Infectious Disease Clinical Trials Introduction
- 7.7.4 ICON Plc Revenue in Infectious Disease Clinical Trials Business (2017-2022)
- 7.7.5 ICON Plc Recent Development
8 Research Findings and Conclusion
9 Appendix
- 9.1 Research Methodology
- 9.1.1 Methodology/Research Approach
- 9.1.2 Data Source
- 9.2 Author Details
Summary:
Market Analysis and Insights: Global and United States Infectious Disease Clinical Trials Market
This report focuses on global and United States Infectious Disease Clinical Trials market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Infectious Disease Clinical Trials market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Phase I accounting for % of the Infectious Disease Clinical Trials global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Vaccines was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Infectious Disease Clinical Trials market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Infectious Disease Clinical Trials Scope and Market Size
Infectious Disease Clinical Trials market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Infectious Disease Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Infectious Disease Clinical Trials market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Infectious Disease Clinical Trials market is segmented into
Phase I
Phase II
Phase III
Phase IV
Segment by Application, the Infectious Disease Clinical Trials market is segmented into
Vaccines
Cell & Gene Therapy
Others
Regional and Country-level Analysis
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Infectious Disease Clinical Trials Market Share Analysis
Infectious Disease Clinical Trials market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Infectious Disease Clinical Trials business, the date to enter into the Infectious Disease Clinical Trials market, Revenue in Infectious Disease Clinical Trials Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
The major vendors covered:
IQVIA
LabCorp
Charles River
WuXi AppTec
Syneos Health
PPD
ICON Plc